The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy-naïve Type 2 diabetes: A placebo-controlled, multicentre study
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Nature in Quality of Life Research
- Vol. 12 (4) , 413-425
- https://doi.org/10.1023/a:1023495106160
Abstract
This prospective, 16-week, randomised, double-blind, parallel-group study assessed the differential impact of the prandial glucose regulating oral hypoglycaemic drug, repaglinide, and placebo upon...Keywords
This publication has 40 references indexed in Scilit:
- Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.Diabetes Care, 2000
- Repaglinide in Type 2 Diabetes: A 24-Week, Fixed-Dose Efficacy and Safety StudyThe Journal of Clinical Pharmacology, 2000
- Pharmacological Management of DiabetesPharmacology & Therapeutics, 1999
- Approaches to the management of postprandial hyperglycaemiaExperimental and Clinical Endocrinology & Diabetes, 1999
- RepaglinideDrugs & Aging, 1998
- Symptoms and Well-Being in Relation to Glycemic Control in Type II DiabetesDiabetes Care, 1996
- Severe Deterioration in Cognitive Function and Personality in Five Patients with Long‐standing Diabetes: A Complication of Diabetes or a Consequence of Treatment?Diabetic Medicine, 1994
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Measures of Psychological Well‐being and Treatment Satisfaction Developed from the Responses of People with Tablet‐treated DiabetesDiabetic Medicine, 1990
- A Measure of Treatment Satisfaction Designed Specifically for People with Insulin‐dependent DiabetesDiabetic Medicine, 1988